Capillary microsampling-based single-cell metabolomics by mass spectrometry and its applications in medicine and drug discovery

Cancer Biomark. 2022;33(4):437-447. doi: 10.3233/CBM-210184.

Abstract

Characterization of cellular metabolic states is a technical challenge in biomedicine. Cellular heterogeneity caused by inherent diversity in expression of metabolic enzymes or due to sensitivity of metabolic reactions to perturbations, necessitates single cell analysis of metabolism. Heterogeneity is typically seen in cancer and thus, single-cell metabolomics is expectedly useful in studying cancer progression, metastasis, and variations in cancer drug response. However, low sample volumes and analyte concentrations limit detection of critically important metabolites. Capillary microsampling-based mass spectrometry approaches are emerging as a promising solution for achieving single-cell omics. Herein, we focus on the recent advances in capillary microsampling-based mass spectrometry techniques for single-cell metabolomics. We discuss recent technical developments and applications to cancer medicine and drug discovery.

Keywords: Capillary microsampling-based single-cell analysis; cell-to-cell variability; mass spectrometry; metabolomics; single-cell applications.

MeSH terms

  • Drug Discovery / methods
  • Humans
  • Mass Spectrometry / methods
  • Metabolomics* / methods
  • Neoplasms* / drug therapy